PetIQ Inc
NASDAQ:PETQ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
PetIQ Inc
Cash & Cash Equivalents
PetIQ Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
PetIQ Inc
NASDAQ:PETQ
|
Cash & Cash Equivalents
$84.1m
|
CAGR 3-Years
46%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Cardinal Health Inc
NYSE:CAH
|
Cash & Cash Equivalents
$4.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
4%
|
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Cash & Cash Equivalents
$136m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
8%
|
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Cash & Cash Equivalents
$135m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-7%
|
|
|
Mckesson Corp
NYSE:MCK
|
Cash & Cash Equivalents
$4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
|
|
Cencora Inc
NYSE:COR
|
Cash & Cash Equivalents
$4.4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
7%
|
|
PetIQ Inc
Glance View
PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. The company is headquartered in Eagle, Idaho and currently employs 1,929 full-time employees. The company went IPO on 2017-07-21. The firm is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels with its branded and distributed medications, as well as health and wellness items, which are further supported by its medications manufacturing facility in Omaha, Nebraska and health and wellness manufacturing facility in Springville, Utah. Its national veterinarian service platform operates in approximately 2,900 retail partner locations in 42 states provides veterinary wellness services. The firm has two segments: Products and Services. The Products segment consists of its manufacturing and distribution businesses. The Services segment consists of veterinary services and related product sales provided by the Company directly to consumers. Its products offering for dogs and cats includes pet Rx medications, OTC medications and wellness products.
See Also
What is PetIQ Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
84.1m
USD
Based on the financial report for Jun 30, 2024, PetIQ Inc's Cash & Cash Equivalents amounts to 84.1m USD.
What is PetIQ Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
18%
Over the last year, the Cash & Cash Equivalents growth was 7%. The average annual Cash & Cash Equivalents growth rates for PetIQ Inc have been 46% over the past three years , 18% over the past five years .